NIZATIDINE clinical trials

A Phase I-II, First-in-Human Study of SKB264 in Patients with Locally Advanced Unresectable /Metastatic Solid Tumors Who are Refractory to Available Standard Therapies

This study is testing a new medicine called SKB264 for people with advanced solid tumours that haven't responded to other treatments. It's a first step to see how safe and effective SKB264 is, and to understand its effects on the body.